Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12116589 Treatment of amyotrophic lateral sclerosis (ALS)

Patent 12116589 was granted and assigned to Voyager Therapeutics on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Voyager Therapeutics
Voyager Therapeutics
0
Date Filed
August 4, 2022
0
Date of Patent
October 15, 2024
0
Patent Application Number
17881193
0
Patent Citations
‌
US Patent 9447433 Synthetic adeno-associated virus inverted terminal repeats
0
‌
US Patent 10597660 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
0
‌
US Patent 10689420 AAV's and uses thereof
0
‌
US Patent 10731155 In vivo production of small interfering RNAs that mediate gene silencing
0
‌
US Patent 10731178 CNS targeting AAV vectors and methods of use thereof
0
‌
US Patent 10920227 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
0
‌
US Patent 11193129 Modulatory polynucleotides
0
‌
US Patent 11198873 Modulatory polynucleotides
0
‌
US Patent 11434502 Treatment of amyotrophic lateral sclerosis (ALS)
0
‌
US Patent 11542506 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
0
•••
Patent Inventor Names
Qingmin Chen
0
Joan R. Coates
0
Holger Patzke
0
Dinah Wen-Yee Sah
0
Jinzhao Hou
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12116589
0
Patent Primary Examiner
‌
Amy Rose Hudson
0
CPC Code
‌
C12N 2310/14
0
‌
C12N 15/113
0

Find more entities like US Patent 12116589 Treatment of amyotrophic lateral sclerosis (ALS)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.